Biosyent Inc (TSE:RX) has released an update.
BioSyent Inc., a growth-oriented specialty pharmaceutical company, has announced a steady second quarter dividend of $0.045 per share for shareholders as of May 31, 2024, maintaining the same rate as the previous quarter. The company remains focused on marketing in-licensed or acquired healthcare products and has a total of 11,585,169 common shares outstanding.
For further insights into TSE:RX stock, check out TipRanks’ Stock Analysis page.
